Summit Rock Advisors, LP Diversified Active

Location: New York, NY

CIK: 0001540951 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 9, 2020

Total Value: $216M (100.0% shares, 0.0% debt)

Holdings (5)

IUSV ISHARES TR 42.9%

Value $92.62M Shares 1,706,039 Est. Cost $54.29 Unrealized —

ACWI ISHARES TR 37.9%

Value $81.93M Shares 1,025,149 Est. Cost $72.57 Unrealized —

HYG ISHARES TR 12.2%

Value $26.38M Shares 314,373 Est. Cost $82.59 Unrealized —

GOVT ISHARES TR 6.4%

Value $13.9M Shares 497,312 Est. Cost $27.95 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 0.6%

Value $1.275M Shares 34,776 Est. Cost $38.42 Unrealized -9.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IUSV	ISHARES TR	1,706,039	$92.62M	42.9%	$54.29	—	CORE S&P US VLU	464287663
ACWI	ISHARES TR	1,025,149	$81.93M	37.9%	$72.57	—	MSCI ACWI ETF	464288257
HYG	ISHARES TR	314,373	$26.38M	12.2%	$82.59	—	IBOXX HI YD ETF	464288513
GOVT	ISHARES TR	497,312	$13.9M	6.4%	$27.95	—	US TREAS BD ETF	46429B267
PHAT	PHATHOM PHARMACEUTICALS INC	34,776	$1.275M	0.6%	$38.42	-9.9%	COM	71722W107